Literature DB >> 31814147

Thirteen-year trends in the prevalence of diabetes in an urban region of Switzerland: a population-based study.

C de Mestral1,2, S Stringhini1,2, I Guessous1, F R Jornayvaz3.   

Abstract

AIM: To assess trends in prevalence of total and diagnosed diabetes, and in the probability of detecting undiagnosed diabetes in the Swiss population.
METHODS: The Bus Santé study is an annual cross-sectional study of adults residing in Geneva state, Switzerland. We included 8532 participants (51% women) from the years 2005 to 2017, when fasting plasma glucose data became available. Total diabetes was defined as the sum of diagnosed and undiagnosed diabetes, while diagnosed diabetes was defined as having a previous diagnosis, and undiagnosed diabetes as having fasting plasma glucose level of ≥7 mmol/l and no previous diagnosis. We calculated the probability of finding undiagnosed diabetes among participants without a diagnosis. We examined for linear and quadratic trends, grouping survey years into five survey periods.
RESULTS: In total, 711 diabetes cases were identified over 13 years. The age- and gender-standardized prevalence of total diabetes decreased between the periods 2005-2009 and 2012-2013 from 9.6% (95% CI 8.3, 10.9) to 7.1% (95% CI 5.8, 8.4), but increased to 8.6% (95% CI 7.3%, 9.9%) by 2016-2017 (P-quadratic <0.01). For diagnosed diabetes, the prevalence decreased between 2005-2009 and 2014-2015 from 8.3% (95% CI 7.0%, 9.5%) to 6.1% (95% CI 5.0%, 7.2%), but increased slightly again to 7.0% (95% CI 5.8%, 8.2%) by 2016-2017 (P-quadratic = 0.01). Men generally had a higher prevalence of total and diagnosed diabetes than women, except in 2016-2017, when the prevalence of total diabetes was 9.5% (95% CI 7.6, 11.5) among men and 7.7% (95% CI 6.0, 9.5) among women (P >0.05). The probability of finding undetected diabetes among participants without a diabetes diagnosis decreased slightly between 2005-2009 and 2012-2013 from 1.5% (95% CI 0.9, 2.0) to 1.0% (95% CI 0.5, 1.5), but increased afterwards to 1.7% (95% CI 1.0, 2.3) by 2016-2017 (P-quadratic = 0.06); in 2016-2017, it was 2.6% (95% CI 1.5, 3.7) among men and 0.7% (95% CI 0.1, 1.3) among women (P <0.01).
CONCLUSION: The prevalence of diabetes has remained relatively constant over time. However, the probability of finding undetected cases of diabetes in the population without diabetes may be increasing among men.
© 2019 Diabetes UK.

Entities:  

Year:  2019        PMID: 31814147     DOI: 10.1111/dme.14206

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

1.  Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva.

Authors:  Judith A Bouman; Sarah Kadelka; Silvia Stringhini; Francesco Pennacchio; Benjamin Meyer; Sabine Yerly; Laurent Kaiser; Idris Guessous; Andrew S Azman; Sebastian Bonhoeffer; Roland R Regoes
Journal:  Epidemics       Date:  2022-05-07       Impact factor: 5.324

2.  Determining the SARS-CoV-2 serological immunoassay test performance indices based on the test results frequency distribution.

Authors:  Farrokh Habibzadeh; Parham Habibzadeh; Mahboobeh Yadollahie; Mohammad M Sajadi
Journal:  Biochem Med (Zagreb)       Date:  2022-06-15       Impact factor: 2.515

3.  Dietary Intake and Diet Quality of Adult Survivors of Childhood Cancer and the General Population: Results from the SCCSS-Nutrition Study.

Authors:  Fabiën N Belle; Angeline Chatelan; Rahel Kasteler; Luzius Mader; Idris Guessous; Maja Beck-Popovic; Marc Ansari; Claudia E Kuehni; Murielle Bochud
Journal:  Nutrients       Date:  2021-05-22       Impact factor: 5.717

4.  Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland.

Authors:  Erin A West; Daniela Anker; Rebecca Amati; Aude Richard; Ania Wisniak; Audrey Butty; Emiliano Albanese; Murielle Bochud; Arnaud Chiolero; Luca Crivelli; Stéphane Cullati; Valérie d'Acremont; Adina Mihaela Epure; Jan Fehr; Antoine Flahault; Luc Fornerod; Irène Frank; Anja Frei; Gisela Michel; Semira Gonseth; Idris Guessous; Medea Imboden; Christian R Kahlert; Laurent Kaufmann; Philipp Kohler; Nicolai Mösli; Daniel Paris; Nicole Probst-Hensch; Nicolas Rodondi; Silvia Stringhini; Thomas Vermes; Fabian Vollrath; Milo A Puhan
Journal:  Int J Public Health       Date:  2020-10-24       Impact factor: 3.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.